NO180434C - Fremgangsmåte for fremstilling av et makrocyklisk aminofosfonsyrekompleks eller et fysiologisk akseptabelt salt derav - Google Patents

Fremgangsmåte for fremstilling av et makrocyklisk aminofosfonsyrekompleks eller et fysiologisk akseptabelt salt derav

Info

Publication number
NO180434C
NO180434C NO903632A NO903632A NO180434C NO 180434 C NO180434 C NO 180434C NO 903632 A NO903632 A NO 903632A NO 903632 A NO903632 A NO 903632A NO 180434 C NO180434 C NO 180434C
Authority
NO
Norway
Prior art keywords
preparing
acceptable salt
physiologically acceptable
phosphonic acid
acid complex
Prior art date
Application number
NO903632A
Other languages
English (en)
Norwegian (no)
Other versions
NO903632D0 (no
NO180434B (no
NO903632L (no
Inventor
Jaime Simon
David Alan Wilson
Joseph R Garlich
David E Troutner
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of NO903632D0 publication Critical patent/NO903632D0/no
Publication of NO903632L publication Critical patent/NO903632L/no
Priority to NO964191A priority Critical patent/NO307056B1/no
Publication of NO180434B publication Critical patent/NO180434B/no
Publication of NO180434C publication Critical patent/NO180434C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3817—Acids containing the structure (RX)2P(=X)-alk-N...P (X = O, S, Se)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/06—Chelate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO903632A 1988-12-19 1990-08-17 Fremgangsmåte for fremstilling av et makrocyklisk aminofosfonsyrekompleks eller et fysiologisk akseptabelt salt derav NO180434C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO964191A NO307056B1 (no) 1988-12-19 1996-10-03 Fremgangsmåte for rensing av 1,4,7,10-tetraazacyklododekan- 1,4,7,10-tetra(metylenfosfonsyre)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/284,876 US5059412A (en) 1984-06-04 1988-12-19 Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
PCT/US1989/005782 WO1990006776A1 (en) 1988-12-19 1989-12-15 Macrocyclic aminophosphonic acid complexes, their preparation, formulations and use

Publications (4)

Publication Number Publication Date
NO903632D0 NO903632D0 (no) 1990-08-17
NO903632L NO903632L (no) 1990-10-17
NO180434B NO180434B (no) 1997-01-13
NO180434C true NO180434C (no) 1997-04-23

Family

ID=23091854

Family Applications (1)

Application Number Title Priority Date Filing Date
NO903632A NO180434C (no) 1988-12-19 1990-08-17 Fremgangsmåte for fremstilling av et makrocyklisk aminofosfonsyrekompleks eller et fysiologisk akseptabelt salt derav

Country Status (26)

Country Link
US (1) US5059412A (de)
EP (2) EP0408701B1 (de)
JP (1) JP2515929B2 (de)
KR (1) KR0178966B1 (de)
CN (1) CN1025983C (de)
AR (1) AR248140A1 (de)
AT (1) ATE112689T1 (de)
AU (3) AU639899B2 (de)
BR (1) BR8907255A (de)
CA (1) CA2005880C (de)
CY (1) CY1902A (de)
DE (1) DE68918852T2 (de)
DK (1) DK175479B1 (de)
ES (1) ES2061010T3 (de)
FI (1) FI101857B1 (de)
HK (1) HK146795A (de)
HU (1) HU207454B (de)
IE (2) IE66391B1 (de)
IL (1) IL92784A (de)
MX (1) MX18786A (de)
NO (1) NO180434C (de)
NZ (1) NZ231818A (de)
PT (1) PT92619B (de)
SA (1) SA91120234B1 (de)
WO (1) WO1990006776A1 (de)
ZA (1) ZA899734B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059412A (en) * 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
US5645818A (en) * 1989-03-24 1997-07-08 Guerbet S.A. Diagnostic compositions comprising a complex formed by a nitrogenous macrocyclic ligand with metal ions
DE4009119A1 (de) * 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
WO1991016075A1 (en) * 1990-04-20 1991-10-31 Australian Nuclear Science & Technology Organisation Bone marrow treatments
AU648315B2 (en) * 1990-06-18 1994-04-21 Dow Chemical Company, The The use of macrocyclic aminophosphonic acid complexes as imaging agents
MC2260A1 (fr) * 1990-06-18 1993-04-26 Dow Chemical Co Formulations de produits radiopharmaceutiques,leur methode d'administration et leur procede de preparation
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5739294A (en) * 1991-12-10 1998-04-14 The Dow Chemical Company Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents
US5320829A (en) * 1991-12-10 1994-06-14 The Dow Chemical Company Oral compositions for inhibiting plaque formation
US5428139A (en) * 1991-12-10 1995-06-27 The Dow Chemical Company Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals
JP3356289B2 (ja) * 1995-06-26 2002-12-16 コンキャット リミティド 第一遷移系列元素に対してキレート化親和性および選択性のある化合物とその医療および診断への使用
US5834456A (en) * 1996-02-23 1998-11-10 The Dow Chemical Company Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms
JP2003501488A (ja) * 1999-06-11 2003-01-14 ネオルックス コーポレイション 骨髄抑制のための高投与量放射性核種錯体
US7094885B2 (en) 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
US6565828B2 (en) * 2000-04-07 2003-05-20 Bristol-Myers Squibb Company Macrocyclic chelants for metallopharmaceuticals
EP1390081A2 (de) 2001-01-08 2004-02-25 Neorx Corporation Therapeutische und diagnostische verbindungen, zusammenstellungen und methoden
US20020094316A1 (en) * 2001-01-09 2002-07-18 Shuang Liu Polypodal chelants for metallopharmaceuticals
WO2003051403A1 (en) * 2001-12-13 2003-06-26 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
US20030228256A1 (en) * 2002-06-11 2003-12-11 Inverardi Luca A. Methods of achieving transplantation tolerance through radioablation of hemolymphopoietic cell populations
WO2007008232A2 (en) 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
WO2011149844A1 (en) * 2010-05-24 2011-12-01 Iso Therapeutics Group Llc Delivery of high dose therapeutic radioisotopes to bone
US10172965B2 (en) 2013-10-07 2019-01-08 Igl Pharma, Inc. High purity therapeutic bone agents
US11369700B2 (en) 2015-05-25 2022-06-28 IGL Pharma Inc. DOTMP kit formulations for radioisotopes
WO2016191413A1 (en) 2015-05-25 2016-12-01 Iso Therapeutics Group, Llc Dotmp kit formulations for radioisotopes
HRP20200922T1 (hr) 2016-09-27 2020-09-18 Bayer Pharma Aktiengesellschaft Postupak za proizvodnju kristalnog oblika modifikacije a kalkobutrola
WO2018148209A1 (en) 2017-02-08 2018-08-16 Iso Therapeutics Group, Llc Method of use for therapeutic bone agents

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965254A (en) * 1973-05-23 1976-06-22 The Procter & Gamble Company Compositions for the treatment of calcific tumors
US4017595A (en) * 1975-08-28 1977-04-12 Research Corporation Bone-seeking indium-113m or indium-111 organic phosphonate complexes
CA1078731A (en) * 1976-12-16 1980-06-03 Charles E. Frosst And Co. Skeletal imaging kit utilizing triethylene tetramine hexa (methylene phosphonic acid)
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US5064633A (en) * 1984-06-04 1991-11-12 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes, their formulations and use
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
US5059412A (en) * 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
DE164843T1 (de) * 1984-06-04 1989-12-07 The Dow Chemical Co., Midland, Mich. Organische aminphosphonsaeurekomplexe fuer die behandlung von verkalkenden tumoren.
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
FR2614020B1 (fr) * 1987-04-14 1989-07-28 Guerbet Sa Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands.
US4853209A (en) * 1987-05-18 1989-08-01 The Dow Chemical Company Bone marrow suppressing agents
US4882142A (en) * 1988-12-19 1989-11-21 The Dow Chemical Company Bone marrow suppressing agents
US4976950A (en) * 1988-12-19 1990-12-11 The Dow Chemical Company Bone marrow suppressing agents

Also Published As

Publication number Publication date
CA2005880C (en) 1999-01-05
PT92619A (pt) 1990-06-29
PT92619B (pt) 1995-09-12
HK146795A (en) 1995-09-22
IL92784A (en) 1994-08-26
NO903632D0 (no) 1990-08-17
WO1990006776A1 (en) 1990-06-28
DE68918852T2 (de) 1995-05-11
MX18786A (es) 1993-12-01
KR0178966B1 (ko) 1999-03-20
DK195990A (da) 1990-08-16
EP0408701A1 (de) 1991-01-23
IE66391B1 (en) 1995-12-27
ZA899734B (en) 1991-08-28
AU657641B2 (en) 1995-03-16
AU639899B2 (en) 1993-08-12
EP0375376A3 (de) 1991-06-12
JPH03502936A (ja) 1991-07-04
DK175479B1 (da) 2004-11-08
EP0375376A2 (de) 1990-06-27
AU4828290A (en) 1990-07-10
CN1025983C (zh) 1994-09-28
FI101857B (fi) 1998-09-15
EP0408701A4 (en) 1991-07-31
DE68918852D1 (de) 1994-11-17
AU5068593A (en) 1994-02-24
AR248140A1 (es) 1995-06-30
HU901163D0 (en) 1991-03-28
ATE112689T1 (de) 1994-10-15
ES2061010T3 (es) 1994-12-01
FI101857B1 (fi) 1998-09-15
KR910700073A (ko) 1991-03-13
NO180434B (no) 1997-01-13
CA2005880A1 (en) 1990-06-19
SA91120234B1 (ar) 2004-09-04
AU4700989A (en) 1990-06-21
BR8907255A (pt) 1991-03-12
EP0408701B1 (de) 1994-10-12
HU207454B (en) 1993-04-28
CY1902A (en) 1989-12-15
IL92784A0 (en) 1990-09-17
HUT54897A (en) 1991-04-29
IE940833L (en) 1990-06-19
CN1046739A (zh) 1990-11-07
DK195990D0 (da) 1990-08-16
US5059412A (en) 1991-10-22
JP2515929B2 (ja) 1996-07-10
IE894063L (en) 1990-06-19
FI904084A0 (fi) 1990-08-17
NO903632L (no) 1990-10-17
NZ231818A (en) 1992-05-26

Similar Documents

Publication Publication Date Title
NO180434C (no) Fremgangsmåte for fremstilling av et makrocyklisk aminofosfonsyrekompleks eller et fysiologisk akseptabelt salt derav
FI894637A0 (fi) Menetelmä mikroemulsion käsittävän farmaseuttisen formulaation valmistamiseksi
FI894342L (fi) Menetelmä syklosporiinia sisältävän farmaseuttisen koostumuksen valmistamiseksi
NO880520L (no) Fremgangsmaate for fremstilling av et cholestyraminpreparat
FI891538A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten fenolisubstituoitujen gem-difosfonaattijohdannaisten valmistamiseksi
NO174277C (no) Fremgangsmåte for fremstilling av et hyaluronsyresalt
PH25030A (en) Phosphinic acid derivatives
PT87754A (pt) Process for the preparation of new amino acid derivatives
FI93214B (fi) Menetelmä ja välituote lääkeaineina käyttökelpoisten 0-(3-amino-2-hydroksipropyyli)-hydroksi-imiinihappohalidien valmistamiseksi
ATA164187A (de) Verfahren zur herstellung eines pharmazeutischen pulvers
FI873106L (fi) Menetelmä jatkuvavapautteisen lääkevalmisteen valmistamiseksi
HUT44043A (en) Process for preparing new amino acid derivatives
ATA18588A (de) Verfahren zur herstellung eines pharmazeutischen trockenpräparates enthaltend ein diclofenac-salz
IL88668A0 (en) Derivatives of cyclic amino acids,a process for the preparation thereof,agents containing them,and the use thereof
HUT53663A (en) Process for producing amino acid derivatives
GB2215720B (en) Process for preparing n-phosphono-methyl-imino-diacetic acid
GR1002249B (en) A process for preparing 1,1-dixo-cephem-carbothiolic acid derivatives
PT87672A (pt) Process for preparing a pharmaceutical composition
GB8924287D0 (en) Process for preparing n-phosphonomethyl-glycine
FI895567A7 (fi) 2-atsabisyklo/2,2,1/hept-5-eeni-2-etikkahappo, sen johdannaiset ja siihen läheisesti liittyvät yhdisteet, menetelmä mainittujen yhdisteiden valmistamiseksi ja mainittujen yhdisteiden käyttö N-fosfonometyyliglys iinin valmistamiseksi
FI895636A0 (fi) Menetelmä imidatsolipitoisten peptidien ja niiden farmaseuttisesti sopivien suolojen valmistamiseksi
ZA8814B (en) A process for the preparation of lipophilic amino acid derivatives,and lipophilic amino acid derivatives
EP0406436A4 (en) Process for preparing 5'-inosinic acid
DE68922839D1 (de) Alpha-Ketosäure/Aminosäure-Salz-Verbindungen und Verfahren zu ihrer Herstellung.
YU135588A (en) Process for preparing derivatives of l-alanyl-l-proline

Legal Events

Date Code Title Description
MK1K Patent expired